# Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

> **NCT04511026** · PHASE2 · TERMINATED · sponsor: **Stanford University** · enrollment: 6 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Lymphoseek
- **DEVICE:** Single Photon Emission Computed Tomography (SPECT)
- **DRUG:** Indocyanine Green (ICG)
- **DEVICE:** Neoprobe Gamma Detection System NPB11L(Model1102)

## Key facts

- **NCT ID:** NCT04511026
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-20
- **Primary completion:** 2021-06-10
- **Final completion:** 2021-06-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Efficacy
- **Last updated:** 2023-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04511026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04511026, "Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04511026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*